Category: Exactech Inc.Syndicate content

Baxter adds 30 jobs in Malta | Medtech personnel moves for the week of Apr. 7, 2014

April 9, 2014 by MassDevice

Here's a look at some of the top personnel stories for medical device companies this week.

Report: Baxter to add 30 jobs in Malta

April 2, 2014 by Arezu Sarvestani

Report: Baxter to add 30 jobs in Malta

Malta regulators announced this week that healthcare titan Baxter plans to add 30 additional jobs in the country.

Z-Medica taps ex-Solta Medical CEO Fanning | Personnel Moves

April 3, 2014 by Brad Perriello

Stephen Fanning, the former CEO of Solta Medical, is Z-Medica's new chief.

Z-Medica taps ex-Solta Medical CEO Fanning

Z-Medica said it named Stephen Fanning, the former CEO of Solta Medical, to be its new chief executive.

Wallingford, Conn.-based Z-Medica is developing blood clotting technologies it calls QuikClot.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Exactech beats Wall Street, boosts earnings guidance after strong Q3

October 24, 2013 by Chris Walker

Exactech beats Wall Street expectations with its 3rd-quarter results and raises its earnings outlook for the rest of the year.

Exactech beats Wall Street, boosts earnings guidance after strong Q3

Exactech (NSDQ:EXAC) beat Wall Street's expectations with its 3rd-quarter earnings and adjusted its outlook for the rest of the year.

Insulet appoints 1st medical director | Personnel Moves

October 17, 2013 by Chris Walker

Insulet Corp. hires the former director of Clinical Research & Technology for the Sansum Diabetes Research Institute, Dr. Howard Zisser, as its 1st medical director.

fired/hired

Insulet (NSDQ:PODD) said it named Dr. Howard Zisser, the former clinical director of the Sansum Diabetes Research Institute, as its 1st medical director.

Considered a leader in diabetes research, Zisser will be involved with a variety of clinical research projects and serve as a medical liaison between Insulet and government leaders, the FDA, and healthcare organizations, Bedford, Mass.-based Insulet said.

Smith & Nephew demands $1M from rival for non-compete violations

August 17, 2012 by MassDevice staff

Smith & Nephew wants rival orthopedics devices maker Exact Surgical to pay $1 million for "willful and intentional" violations of a former sales rep's non-compete and nondisclosure agreements.

legal gavel, lawsuit art

Orthopedic titan Smith & Nephew (FTSE:SN, NYSE:SNN) sued rival device maker Exact Surgical for $1 million dollars for hiring a former S&M rep to sell orthopedic devices in Texas.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Thoratec kills it in Q1, Wall Street shrugs | Earnings Roundup

May 2, 2012 by MassDevice staff

Thoratec leaves Wall Street analysts in the dust with its 1st quarter earnings, beating expectations by 10¢, but the initial bump fades as investors back off after sending shares up more than 7% this morning; also, Allergan's Q1 sales rise, earnings soar; Endologix's sales spike, losses soar; Q1 profits plunge for Greatbatch; Hospira's Q1 sales slip, earnings slide; ResMed's Q3 sales, earnings up; and more.

MassDevice.com news

Thoratec (NSDQ:THOR) started today up 7.2% as investors reacted to its stellar 1st-quarter numbers, but by the time the market closed THOR shares had fallen back to Earth to close at $34.46, down 0.1%.

The heart pump maker posted profits of $25.5 million, or 43¢ per diluted share, on sales of $126.8 million for the 3 months ended March 31.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic enrolls 1st patient in epileptic brain-stim registry | MassDevice.com On Call

March 16, 2012 by MassDevice staff

Medtronic enrolls the initial patient into its Medtronic Registry for Epilepsy to look at the long-term efficacy and safety of deep brain stimulation therapy for patients with drug-resistant epilepsy.

MassDevice On Call

MASSDEVICE ON CALL — As neuromodulation therapy celebrates its 25th year, Medtronic (NYSE:MDT) enrolled the 1st patient into its Medtronic Registry for Epilepsy, a database tracking the safety, efficacy and quality of life of patients receiving deep-brain stimulation for treatment of drug-resistant epilepsy.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp